The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7)

British Journal of Cancer

Volumn 78, Issue 1, 1998, Pages 111-118

  Bagheri Yarmand, R ^a   Kourbali, Y ^a   Mabilat, C ^b   Morere J F ^c   Martin, A ^d   Lu, H ^b   Soria, C ^b   Jozefonvicz, J ^a   Crepin M ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c Grp Nord d'Oncol M   (France)

^d Service d'Anatomie Pathologie   (France)

Author keywords

Angiogenesis; Breast cancer; Dextran derivative; Fibroblast growth factor

Indexed keywords

ANTIMITOTIC AGENT; CARBOXYMETHYL BENZYLAMIDE DEXTRAN; DEXTRAN DERIVATIVE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; GROWTH FACTOR; HEPARIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER TRANSPLANTATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MITOGENESIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PULMONARY ARTERY; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR GROWTH; TUMOR NECROSIS; UMBILICAL VEIN;

EID: 0031807196     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.451     Document Type: Article

References (36)

1. Alroy J, Goyal V and Skutelsky E (1987) Lectin histochemistry of mammalian endothelium. Histochemistry 86: 603-607
2. Bagheri-Yarmand R, Bittoun P, Champion J, Letourneur D, Jozefonvics J, Fermandjian S and Crépin M (1994) Carboxymethyl benzylamide dextrans inhibit breast cell growth. In vitro Cell Dev Biol 30A: 822-824
3. Bagheri-Yarmand R, Liu JF, Ledoux D, Morère JF and Crépin M (1997) Inhibition of human breast epithelial HBL100 cell proliferation by a dextran derivative (CMDB7): interference with the FGF2 autocrine loop. Biochem Biophys Res Comm 239: 424-428
4. Basilico C and Moscatelli D (1992) The FGF family of growth factors and oncogenes. Cancer Res 59: 115-164
5. Chaubet F, Champion J, Maïga R, Maurey S and Jozefonvicz J (1995) Synthesis and structure-anticoagulant property relationships of functionalized dextrans: CMDBS. Carbohydrate Polymers 28: 145-152
6. Czubayko F, Smith RV, Chung HC and Wellstein A (1994) Tumour growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J Biol Chem 269: 28243-28248
7. Dickson C, Smith R, Brookes S, Peters G (1984) Tumorigenesis by mouse mammary tumour virus: proviral activation of a cellular gene in the common integration region int-2. Cell 37: 529-536
8. Folkman J (1990) What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
9. Folkman J and Klagsbrun M (1987) Angiogenic factors. Science 235: 442-447
10. Gomm JJ, Smith J, Ryall GK, Baillie R, Turnbull L and Coombes RC (1991) Localisation of basic fibroblast growth factor and transforming growth factor β1 in the human mammary gland. Cancer Res 51: 4685-4692
11. Gualandris A, Urbinati C, Rusnati M, Ziche M and Presta M (1994) Interaction of high molecular weight basic fibroblast growth factor (bFGF) with endothelium: biological activity and intracellular fate of human recombinant mr 24000 bFGF. J Cell Physiol 161: 149-159
12. Gualandris A, Rusnati M, Belleri M, Nelli EE, Bastaki M, Molinari-Tosatti MP, Bonardi F, Parolini S, Albini A, Morbidelli L, Ziche M, Corallini A, Possati L, Vacca A, Ribatti D and Presta M (1996) Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth Differ 7: 147-160
13. Hlatky L, Tsionou C, Hahnfeldt P, Coleman CN (1994) Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res 54: 6083-6086
14. Hori A, Sasada R, Matsutani E, Naito K, Sakura Y, Fujita T and Kazai Y (1991) Suppression of solid tumour growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 51: 6180-6184
15. Kim KJ, Bing L, Winer J, Armanini M, Gillett N, Phillips HS and Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-845
16. Klagsbrun M (1989) The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res 1: 207-235
17. Lebeau J, Chalony L, Prosperi MT and Goubin G (1991) Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene. Oncogene 6: 1125-1132
18. Liu JF, Bagheri-Yamand R, Xia Y and Crépin M (1997) Modulations of breast fibroblast and carcinoma cell interactions by a dextran derivative (CMDB7). Anticancer Res 17: 253-258
19. Mcleskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB and Kern FG (1993) Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumourigenic and metastatic in ovariectomized of tamoxifen-treated athymic nude mice. Cancer Res 53: 2168-2177
20. Miyamoto M, Naruo K, Seko C, Matsumoto S, Kondo T and Kurokawa T (1993) Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 13: 4251-4259
21. Morère JF, Planchon P, Letourneur D, Avramoglou T, Jozefonvicz J, Israel L and Crépin M (1992) Inhibitory effect of substituted dextrans on MCF7 human breast cancer cell growth in vitro. Anticancer Drug 3: 629-634
22. Murakami A, Tanaka H and Matsuzawa A (1990) Association of hst gene expression with metastatic phenotype in mouse mammary tumours. Cell Growth Differ 1: 1-5
23. Nguyen H, Watanabe H, Budson AE, Richie JP, Hayes DF and Folkman J (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86: 356-361
24. Penault-Lorca F, Bertucci F, Adelaide J, Parc P, Coulier F, Jacquemier J, Birnbaum D and Delapeyriere O (1995) Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 61: 170-176
25. Polanowski F, Gaffney EV and Burke RE (1976) HBL-100, a cell line established from human milk. In vitro Cell Dev Biol 12: 328-328
26. Sato Y and Rifkin DB (1988) Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 110: 1199-1205
27. Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC and Gospodarowicz D (1987) Capillary endothelial express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325: 257-259
28. Souttou B, Hamelin R and Crépin M (1994) FGF2 as an autocrine growth factor for immortal human breast epithelial cells. Cell Growth Differ 5: 615-623
29. Souttou B, Gamby C, Crépin M and Hamelin R (1996) Tumoral progression of human breast epithelial cells secreting FGF2 and FGF4. Int J Cancer 68: 675-681
30. Takei Y, Kurobe M, Uchida A and Hayashi K (1993) Presence of high-molecular-weight basic growth-factor-like immunoreactive substance in sera of patients with breast cancer. J Clin Biochem Nutr 15: 57-64
31. Tanaka A, Miyamoto K, Minamino N, Takeda M, Sato H, Matsuo H and Matsumoto K (1992) Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cell. Proc Natl Acad Sci 89: 8928-8932
32. Theillet C, Le Roy X, Delapeyriere O, Grosgeorges J, Adnane J, Raynaud SD. Simony-Lafontaine J, Goldfarb M, Escot C and Birnbaum D (1989) Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. Oncogene 4: 915-922
33. Tsuboi R, Sato Y and Rifkin DB (1990) Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells. J Cell Biol 110: 511-517
34. Vaisman N, Gospodarowicz D and Neufeld G (1990). Characterization of the receptor for vascular endothelial growth factor. J Biol Chem 256: 19461-19466
35. Vartanian RK and Weidner N (1994) Correlation of intratumoural endothelial cell proliferation with microvessel density (tumour angiogenesis) and tumour cell proliferation in breast carcinoma. Am J Pathol 6 (144): 1188-1194
36. Wellstein A, Zugmaier G, Califano JA, Kern F, Paik S and Lippman ME (1991) Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J Natl Cancer Inst 83: 716-720